Huadong Medicine Co., Ltd (SHE:000963)
42.42
+0.02 (0.05%)
Sep 18, 2025, 2:45 PM CST
Huadong Medicine Market Cap
Huadong Medicine has a market cap or net worth of 74.19 billion as of September 18, 2025. Its market cap has increased by 40.47% in one year.
Market Cap
74.19B
Enterprise Value
72.14B
Revenue
42.62B
Ranking
n/a
PE Ratio
20.53
Stock Price
42.42
Market Cap Chart
Since January 2, 2001, Huadong Medicine's market cap has increased from 4.21B to 74.19B, an increase of 1,662.14%. That is a compound annual growth rate of 12.31%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 17, 2025 | 74.19B | 22.53% |
Dec 31, 2024 | 60.55B | -16.55% |
Dec 29, 2023 | 72.56B | -11.60% |
Dec 30, 2022 | 82.09B | 16.70% |
Dec 31, 2021 | 70.34B | 51.36% |
Dec 31, 2020 | 46.47B | 8.94% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Jiangsu Hengrui Medicine | 467.07B |
WuXi AppTec | 317.76B |
Shenzhen Mindray Bio-Medical Electronics | 289.52B |
Sichuan Biokin Pharmaceutical | 149.17B |
Shanghai United Imaging Healthcare | 124.32B |
Zhangzhou Pientzehuang Pharmaceutical., | 121.54B |
Aier Eye Hospital Group | 119.73B |
Yunnan Baiyao Group Co.,Ltd | 105.22B |